Genomic studies of thyroid SMECE have so far been largely uninformative, showing a notable absence of MAML2 rearrangements characteristic of mucoepidermoid carcinoma or BRAF mutations [23–25]. This evidence concerns the gene MAML2 and thyroid gland disorder.